Skip to content

Regional lung ventilation in children via X-ray Velocimetry (XV)

Feasibility study of paediatric regional lung function assessment via X-ray Velocimetry (XV) imaging in children with healthy lungs or cystic fibrosis and other chronic lung diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12623000109606
Enrollment
30
Registered
2023-02-01
Start date
2022-11-03
Completion date
2026-06-30
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Lung health is mostly measured by “blowing tests”, known as spirometry. These types of tests can give useful information about lung health, but they can’t show exactly where in the lung any disease may be present. Other tests like computed tomography (CT) can give doctors useful and detailed information about the structure of the lungs, but this is different information to measuring how the lung is actually working as you breathe. We are trialing a new test called XV LVAS which will show how well different areas of the lung are working. This test is not currently approved for use in children but might help doctors to treat conditions like cystic fibrosis. We are recruiting children with healthy lungs and children with cystic fibrosis and other chronic lung diseases to decide if this test should be used with other lung tests to help doctors treat lung diseases like cystic fibrosis.

Interventions

We are investigating the feasibility of undertaking regional lung function imaging of children with healthy lungs, and children with CF or other chronic lung diseases, as revealed by X-ray Velocimetry (XV). This XV LVAS technology which has not been utilised in a paediatric cystic fibrosis population previously. This will be compared to CT and lung function testing which is the current gold standard of care for CF patients. This will be a single time point comparison with one set of imaging and

We are investigating the feasibility of undertaking regional lung function imaging of children with healthy lungs, and children with CF or other chronic lung diseases, as revealed by X-ray Velocimetry (XV). This XV LVAS technology which has not been utilised in a paediatric cystic fibrosis population previously. This will be compared to CT and lung function testing which is the current gold standard of care for CF patients. This will be a single time point comparison with one set of imaging and lung function per participant. XV LAS imaging requires a series of 5 x-rays taken from different angles around the chest while the patient is breathing normally and will take about 5 minutes of imaging. X-rays are acquired over the duration of one normal breath at each position. This allows specialist software (XV LAS, 4Dmedical) to examine the CT scan with the x-ray images to show how well each lung segment is working. This provides additional information compared to CT scans, x-rays or lung function testing on their own as it shows a heat map of the lung, identifying how well regions of the lung are functioning. This additional information can help advise doctors on whether treatments such as medications and physiotherapy are working well or need to be modified as well as mapping any structural changes. Participants will be asked to attend clinic for 30 minutes for consent, a physical exam and medical history, then attend lung function for 1.5-2 hours to complete lung function testing (spirometry, lung volume, diffusing capacity) and radiology for 30 minutes for the XV LVAS x-rays. These activities can be spread across different days or correspond with other hospital appointments if necessary to reduce patient burden.

Sponsors

Women's and Children's Hospital, Department of Respiratory and Sleep Medicine
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
3 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Age 3-18 years, male or female 2. CT scan performed within last 3 months or scheduled for clinical CT scan 3. Belong to one of the following arms: Arm 1 - Control Arm 2 - Cystic Fibrosis Arm 3 - Chronic Lung Disease

Exclusion criteria

1. Currently receiving mechanical ventilation, intensive or other critical care 2, Contraindication to ionizing radiation 3. Pre-existing lung disease in Arm 1 - Control patients, e.g. asthma, interstitial lung disease, etc 4. Urgent clinical treatment precluding XV imaging 5. Inability to comply and remain still for periods of 30 seconds for the five XV image acquisitions 6. Unable to perform standard lung function testing

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 7, 2026